Trials / Unknown
UnknownNCT04590378
Pulmonary Embolism and COVID-19
Evaluation of the Patients With COVID-19 in Terms of Pulmonary Embolism
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Uşak University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
The charts of patients who developed pulmonary embolism in the course of COVID-19 will be evaluated, retrospectively. Clinical features and laboratory data will be analyzed.
Detailed description
Patients with COVID-19 infection will be evaluated retrospectively. Demographic data, clinical and laboratory findings will be recorded. Findings of patients with pulmonary embolism and withour pulmonary embolism will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | intensive care unit admission ratio | intensive care unit admission ratio |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2021-06-01
- Completion
- 2021-12-01
- First posted
- 2020-10-19
- Last updated
- 2021-05-04
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04590378. Inclusion in this directory is not an endorsement.